Inventor
REICH SIEGFRIED H
US24 patents
⚠️ This page may combine multiple inventors who share the name “REICH SIEGFRIED H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
EFFECTOR THERAPEUTICS INC
14 patentsUS9814718B2Nov 14, 2017
MNK inhibitors and methods related thereto
EFFECTOR THERAPEUTICS INC5 citations83
US9669031B2Jun 6, 2017
MNK inhibitors and methods related thereto
EFFECTOR THERAPEUTICS INC12 citations83
US9382248B2Jul 5, 2016
Mnk inhibitors and methods related thereto
EFFECTOR THERAPEUTICS INC14 citations83
US10577378B2Mar 3, 2020
EIF4A-inhibiting compounds and methods related thereto
EFFECTOR THERAPEUTICS INC6 citations81
US9957277B2May 1, 2018
eIF4A-inhibiting compounds and methods related thereto
EFFECTOR THERAPEUTICS INC6 citations81
US10793551B2Oct 6, 2020
Benzimidazole-indole inhibitors of Mnk1 and Mnk2
EFFECTOR THERAPEUTICS INC2 citations72
US11083727B2Aug 10, 2021
Piperidine-substituted Mnk inhibitors and methods related thereto
EFFECTOR THERAPEUTICS INC2 citations71
US11130757B2Sep 28, 2021
Crystalline forms of MNK inhibitors
EFFECTOR THERAPEUTICS INC2 citations70
US10112955B2Oct 30, 2018
Isoindoline, azaisoindoline, dihydroindenone and dihydroazaindenone inhibitors of Mnk1 and Mnk2
EFFECTOR THERAPEUTICS INC2 citations70
US11878015B2Jan 23, 2024
Piperidine-substituted Mnk inhibitors and methods related thereto
EFFECTOR THERAPEUTICS INC0 citations61
US11952375B2Apr 9, 2024
Crystalline forms of Mnk inhibitors
EFFECTOR THERAPEUTICS INC0 citations60
US11440917B2Sep 13, 2022
EIF4A-inhibiting compounds and methods related thereto
EFFECTOR THERAPEUTICS INC1 citations60
US11286268B1Mar 29, 2022
EIF4E-inhibiting compounds and methods
EFFECTOR THERAPEUTICS INC1 citations57
US11014926B2May 25, 2021
Pyrrolo-, pyrazolo-, imidazo-pyrimidine and pyridine compounds that inhibit MNK1 and MNK2
EFFECTOR THERAPEUTICS INC0 citations51
AGOURON PHARMA
10 patentsUS5484926AJan 16, 1996
HIV protease inhibitors
AGOURON PHARMA158 citations99
US5856530AJan 5, 1999
Antipicornaviral compounds and methods for their use and preparation
AGOURON PHARMA32 citations91
US5863950AJan 26, 1999
HIV protease inhibitors
AGOURON PHARMA44 citations88
US5714518AFeb 3, 1998
HIV protease inhibitors and methods of making the same
AGOURON PHARMA42 citations88
US6362166B1Mar 26, 2002
Antipicornaviral compounds and methods for their use and preparation
AGOURON PHARMA14 citations82
US5859002AJan 12, 1999
HIV protease inhibitors
AGOURON PHARMA6 citations73
US6214799B1Apr 10, 2001
Antipicornaviral compounds and methods for their use and preparation
AGOURON PHARMA11 citations72
US6001851ADec 14, 1999
HIV protease inhibitors
AGOURON PHARMA4 citations60
US6953858B2Oct 11, 2005
HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
AGOURON PHARMA4 citations57
US7179918B2Feb 20, 2007
HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
AGOURON PHARMA0 citations47